Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04104243 · ClinicalTrials.gov registry record · NA
Power-Up: An Effectiveness Trial of the Diabetes Prevention Program
A NA study of Type 2 Diabetes and Pre Diabetes, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
- 1
- Study location
NCT04104243 is a NA study of Type 2 Diabetes and Pre Diabetes that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 301 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04104243, a NA study of Type 2 Diabetes and Pre Diabetes, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to address the risk of diabetes among men by creating a Diabetes Prevention Program (DPP) tailored to men.
Conditions Studied
Interventions
- OTHER Men-Tailored DPP (Power-Up)
Study Locations (1)
New York
- Albert Einstein College of Medicine - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2021-08-09 |
| Est. Completion | 2025-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04104243
The ClinicalTrials.gov registry entry for NCT04104243 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (73% lower). The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Men-Tailored DPP (Power-Up) is the first listed.
NCT04104243 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04104243 about?
NCT04104243 is a clinical study titled "Power-Up: An Effectiveness Trial of the Diabetes Prevention Program". The goal of this study is to address the risk of diabetes among men by creating a Diabetes Prevention Program (DPP) tailored to men.
What is the current status of trial NCT04104243?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2021-08-09. Estimated completion is 2025-02-07.
What conditions does trial NCT04104243 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Pre Diabetes.
What interventions are being tested in trial NCT04104243?
The interventions under investigation include: Men-Tailored DPP (Power-Up) (OTHER).
Who is sponsoring clinical trial NCT04104243?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04104243 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.